I know it is pretty obvious but Injective (INJUSD) is doing much better than most of the Altcoins.
First, many pairs completed their initial bullish wave right back in January, some continued to move through February but that is about it for the majority of Altcoins. Looking at INJUSD, we can see that it grew all the way through April.
Another variation in the pattern is the correction. After hitting a low in May is has been consolidating up. The chart looks pretty good and overall supports additional growth, with a long-term strength bias.
The 12-May low can be a good support level if one is looking to trade. The rest is up.
Namaste.
First, many pairs completed their initial bullish wave right back in January, some continued to move through February but that is about it for the majority of Altcoins. Looking at INJUSD, we can see that it grew all the way through April.
Another variation in the pattern is the correction. After hitting a low in May is has been consolidating up. The chart looks pretty good and overall supports additional growth, with a long-term strength bias.
The 12-May low can be a good support level if one is looking to trade. The rest is up.
Namaste.
🚨 The difference between poor weak signals & PREMIUM trade-numbers lies in results. Stand apart from the crowd. #1 Since 2017. Join now 👉 t.me/lamatrades/4
🎯 LIFETIME Results: t.me/anandatrades/1183
(Click now & get FREE Pizza! 🍕)
🎯 LIFETIME Results: t.me/anandatrades/1183
(Click now & get FREE Pizza! 🍕)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
🚨 The difference between poor weak signals & PREMIUM trade-numbers lies in results. Stand apart from the crowd. #1 Since 2017. Join now 👉 t.me/lamatrades/4
🎯 LIFETIME Results: t.me/anandatrades/1183
(Click now & get FREE Pizza! 🍕)
🎯 LIFETIME Results: t.me/anandatrades/1183
(Click now & get FREE Pizza! 🍕)
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.